fremanezumab has completed phase iii trials and is under review by the fda to prevent migraine and
.: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies."
. a senior northern ireland civil servant has apologised after hundreds of neurology patients were recalled for further testing.
.
'indian ip and liabilities law barrier to pharma r&d investment'
.
.
.
. here again, unity is our greatest strength. "the eu and u.s. are friends and partners". trump says the tariffs are needed for national security reasons.
.
stephen silberstein, md, director, jefferson university headache center.
.
.